EMCM acquired by Private Equity firm

February 25, 2014

European Medical Contract Manufacturing B.V. (EMCM) today announces its acquisition by a British Virgin Island-based Private Equity Company for a price of EUR 18Mn. The transfer of ownership and control is to be completed in April 2014.

The transaction facilitates EMCM’s vision to roll out the supercritical carbon dioxide based, eCOO Technology offering, for products and services. The new shareholder shall additionally support in the enhancement of its contract manufacturing competencies to its existing and future clientele.

The alliance provides EMCM a sound mix of geographic access to high growth markets of China, Japan and Southeast Asia, and timely incorporation of value added services in EMCM’s contract manufacturing business for regenerative tissue products, biologicals and biomaterials. The new shareholder shall additionally contribute in the go-to-market strategies of the eTiss, eColl & eNova products.

With this synergistic alliance, EMCM continues to provide high quality and reliable products and services that support opportunities in orthopaedics, dental, wound care and cardiovascular segments.